NasdaqCM - Delayed Quote USD

SELLAS Life Sciences Group, Inc. (SLS)

1.5200 -0.0200 (-1.30%)
At close: April 25 at 4:00 PM EDT
1.5300 +0.01 (+0.66%)
Pre-Market: 8:48 AM EDT
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
6,219.0000
20,943.0000
26,275.0000
46,049.0000
Total Liabilities Net Minority Interest
14,195.0000
16,092.0000
5,928.0000
18,088.0000
Total Equity Gross Minority Interest
-7,976.0000
4,851.0000
20,347.0000
27,961.0000
Total Capitalization
-7,976.0000
4,851.0000
20,347.0000
27,961.0000
Common Stock Equity
-7,976.0000
4,851.0000
20,347.0000
27,961.0000
Capital Lease Obligations
906.0000
945.0000
808.0000
991.0000
Net Tangible Assets
-9,890.0000
2,937.0000
18,433.0000
20,347.0000
Working Capital
-10,563.0000
2,241.0000
18,062.0000
24,589.0000
Invested Capital
-7,976.0000
4,851.0000
20,347.0000
27,961.0000
Tangible Book Value
-9,890.0000
2,937.0000
18,433.0000
20,347.0000
Total Debt
906.0000
945.0000
808.0000
991.0000
Share Issued
32,132.8900
21,005.4050
15,895.6370
14,254.5540
Ordinary Shares Number
32,132.8900
21,005.4050
15,895.6370
14,254.5540
12/31/2020 - 3/12/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers